ProCE Banner Activity

An Interactive Online Tool Featuring Expert Recommendations for Advanced NSCLC

Clinical Thought
Are you interested in seeing treatment recommendations from 5 lung cancer experts?

Released: August 05, 2016

Expiration: August 04, 2017

No longer available for credit.

Share

Faculty

David R. Gandara

David R. Gandara, MD

Professor of Clinical Medicine
Associate Director for Clinical Research
University of California Davis Cancer Center
Davis, California

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

AbbVie

Celgene

Genentech Roche Virology

Lilly

Merck Oncology

Novartis Pharmaceuticals Corporation

Faculty Disclosure

Primary Author

David R. Gandara, MD

Professor of Clinical Medicine
Associate Director for Clinical Research
University of California Davis Cancer Center
Davis, California

David R. Gandara, MD, has disclosed that he has received funds for research support from AstraZeneca, Bristol-Myers Squibb, Clovis, Genentech, Johnson & Johnson, Lilly, Merck, and Novartis and consulting fees from Ariad, AstraZeneca, Boehringer-Ingelheim, Celgene, Clovis, Genentech, Guardant Health, Lilly, Merck, Mirati, Novartis, and Pfizer.